PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $136 | -20.5% | 13,184 | +0.8% | 0.00% | – |
Q2 2023 | $171 | -31.3% | 13,076 | -41.4% | 0.00% | – |
Q1 2023 | $249 | +18.0% | 22,309 | -10.8% | 0.00% | – |
Q4 2022 | $211 | -99.9% | 25,009 | +0.1% | 0.00% | -100.0% |
Q3 2022 | $416,000 | +28.0% | 24,981 | +13.1% | 0.00% | – |
Q2 2022 | $325,000 | -40.8% | 22,091 | -0.2% | 0.00% | -100.0% |
Q1 2022 | $549,000 | -6.6% | 22,126 | +20.7% | 0.00% | 0.0% |
Q4 2021 | $588,000 | -11.0% | 18,324 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $661,000 | -31.6% | 18,370 | -16.1% | 0.00% | 0.0% |
Q2 2021 | $966,000 | +13.5% | 21,893 | +17.6% | 0.00% | 0.0% |
Q1 2021 | $851,000 | +35.5% | 18,610 | +104.5% | 0.00% | 0.0% |
Q4 2020 | $628,000 | – | 9,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
Yu Fan | 303,030 | $13,861,000 | 36.18% |
ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
Miura Global Management | 405,000 | $18,525,000 | 3.31% |
GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |